PACAP-38 vs Davunetide

Head-to-head comparison of PACAP-38 (Pituitary Adenylate Cyclase-Activating Polypeptide-38 (human PACAP-38)) and Davunetide (Activity-Dependent Neuroprotective Protein fragment NAP (NAPVSIPQ)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyPACAP-38Davunetide
CategoryCognitive EnhancementCognitive Enhancement
Full NamePituitary Adenylate Cyclase-Activating Polypeptide-38 (human PACAP-38)Activity-Dependent Neuroprotective Protein fragment NAP (NAPVSIPQ)
Molecular Weight4534 Da796.9 Da
Half-Lifeminutesshort; minutes to low hours
Amino Acids38 aa8
Typical Dose10-100 µg preclinical range1-10 mg/day research range
RouteIntranasalIntranasal
Purity≥98%≥98%
Studies Count65040
Research StatusPre-clinicalClinical/Pre-clinical

PACAP-38 Benefits

  • synaptic plasticity
  • BDNF upregulation
  • neuroprotection
  • memory consolidation

Davunetide Benefits

  • neuroprotection
  • microtubule support
  • attention support
  • memory preservation

PACAP-38 Dosing

0.1-1 nmol ICV in rodents|10-100 µg intranasal in preclinical studies|single-dose or short repeated protocols

Davunetide Dosing

intranasal research dosing|1-10 mg per dose in trials/preclinical work|once or twice daily

PACAP-38 Side Effects

  • headache-like effects
  • flushing
  • hypotension

Davunetide Side Effects

  • nasal irritation
  • headache
  • limited efficacy in late-stage trials

Research Overview

PACAP-38

PACAP-38 is one of the most studied endogenous neuropeptides for protecting neurons from ischemic and excitotoxic damage. Preclinical literature also links it to hippocampal plasticity and learning-related signaling, including increased BDNF expression.

Davunetide

Preclinical work showed davunetide can protect neurons, preserve synaptic structure, and improve performance in memory tasks. Human trials largely focused on neurodegenerative disease outcomes rather than stand-alone nootropic use, but the literature supports CNS activity.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

PACAP-38 stacks with:

citicolinealpha-gpcomega-3

Davunetide stacks with:

gpenoopeptdesmopressin
neurotrophicbdnfsynaptic-plasticityneuroprotectionoctapeptideADNP